Michael C. Cameron, MD: Reflecting on Real-World Abrocitinib; An investigator argues for greater prescriber understanding and communication of real-world efficacy and safety outcomes for the latest oral JAK inhibitor approved for atopic dermatitis.

Media coverage

• Title	Michael C. Cameron, MD: Reflecting on Real-World Abrocitinib; An investigator argues for greater prescriber understanding and communication of real-world efficacy and safety outcomes for the latest oral JAK inhibitor approved for atopic dermatitis.
  Media name/outlet	Consultant Live
  Country/Territory	United States
  Date	13/06/23
  URL	metabase.moreover.com/noarticleurl?type=psh&lni=68FY-W491-JCXN-V325-00000-00
  Persons	Michael Cameron

• Title	Michael C. Cameron, MD: Reflecting on Real-World Abrocitinib
  Media name/outlet	HCP Live
  Country/Territory	United States
  Date	13/06/23
  URL	metabase.moreover.com/noarticleurl?type=psh&lni=68G0-0DY1-JCXN-V1MS-00000-00
  Persons	Michael Cameron